[go: up one dir, main page]

CL2007002229A1 - Construccion peptidica dendrimetrica; procedimiento de preparacion de dicha construccion peptidica; composicion veterinaria que comprende dicha construccion; uso de dicha construccion peptidica para prevenir la fiebre aftosa en un animal. - Google Patents

Construccion peptidica dendrimetrica; procedimiento de preparacion de dicha construccion peptidica; composicion veterinaria que comprende dicha construccion; uso de dicha construccion peptidica para prevenir la fiebre aftosa en un animal.

Info

Publication number
CL2007002229A1
CL2007002229A1 CL200702229A CL2007002229A CL2007002229A1 CL 2007002229 A1 CL2007002229 A1 CL 2007002229A1 CL 200702229 A CL200702229 A CL 200702229A CL 2007002229 A CL2007002229 A CL 2007002229A CL 2007002229 A1 CL2007002229 A1 CL 2007002229A1
Authority
CL
Chile
Prior art keywords
construction
peptidic
dendrimetric
affose
fever
Prior art date
Application number
CL200702229A
Other languages
English (en)
Inventor
Blanco Lavilla Carolina Esther
Original Assignee
Inst Nac De Invest Y Tecn Agra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nac De Invest Y Tecn Agra filed Critical Inst Nac De Invest Y Tecn Agra
Publication of CL2007002229A1 publication Critical patent/CL2007002229A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • C07K14/09—Foot-and-mouth disease virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL200702229A 2006-08-02 2007-07-31 Construccion peptidica dendrimetrica; procedimiento de preparacion de dicha construccion peptidica; composicion veterinaria que comprende dicha construccion; uso de dicha construccion peptidica para prevenir la fiebre aftosa en un animal. CL2007002229A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200602142A ES2319483B1 (es) 2006-08-02 2006-08-02 Construccion peptidica dendrimerica para la prevencion de la fiebre aftosa en animales.

Publications (1)

Publication Number Publication Date
CL2007002229A1 true CL2007002229A1 (es) 2008-06-13

Family

ID=38996906

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200702229A CL2007002229A1 (es) 2006-08-02 2007-07-31 Construccion peptidica dendrimetrica; procedimiento de preparacion de dicha construccion peptidica; composicion veterinaria que comprende dicha construccion; uso de dicha construccion peptidica para prevenir la fiebre aftosa en un animal.

Country Status (5)

Country Link
EP (1) EP2053056B1 (es)
AR (1) AR062182A1 (es)
CL (1) CL2007002229A1 (es)
ES (1) ES2319483B1 (es)
WO (1) WO2008015309A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2647390A1 (en) * 2012-04-02 2013-10-09 Universitat Pompeu-Fabra Peptide vaccines for the prevention of foot-and-mouth disease
CN104311673B (zh) * 2014-10-22 2017-04-12 申联生物医药（上海）股份有限公司 固相片段法制备猪o型口蹄疫合成肽抗原2800的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107021A (en) * 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease

Also Published As

Publication number Publication date
WO2008015309A1 (es) 2008-02-07
ES2319483A1 (es) 2009-05-07
EP2053056A1 (en) 2009-04-29
EP2053056B1 (en) 2012-12-26
EP2053056A4 (en) 2010-09-08
ES2319483B1 (es) 2010-02-10
AR062182A1 (es) 2008-10-22

Similar Documents

Publication Publication Date Title
CL2007002128A1 (es) Derivados de n'-ciano-n-halogenoalquil-imidamida; procedimiento para la preparacion de dicho compuesto; composiciones farmaceuticas que lo contienen; y uso del compuesto para combatir parasitos animales.
BRPI0810863A2 (pt) Uso de hidrolisados de proteína para estabilizar formulações de detergente de metaloprotease.
CL2007002971A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CL2007002094A1 (es) Combinaciones que contienen cetoenoles ciclicos y al menos uno de los compuestos cienopirafeno, ciflumetofeno, e ika2002; agentes que las comprenden y procedimiento de preparacion; procedimiento para combatir plagas animales; y uso de las mismas.
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
CL2009001484A1 (es) Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia.
CL2007002837A1 (es) Uso de fenitoina para tratar mucositis oral.
BRPI0918359A2 (pt) composto, composição agroquímica, uso da composição agroquímica e método para preparação do composto
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
BRPI0821004A2 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
CL2011000986A1 (es) Compuestos halosustituidos; uso de dichos compuestos para combatir plagas animales; procedimiento para la preparacion de fitoprotectores; procedimiento para combatir plagas; y compuestos intermediarios.
CU23871B1 (es) Composiciones y métodos de uso para anticuerpos de dickkopf-1
BR112012016398A2 (pt) Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa
CL2007002818A1 (es) Procedimiento para combatir plagas animales u hongos fitopatogenos; composicion agroquimica para la aplicacion en el suelo que contiene al menos un principio activo agroquimico y un adyuvante; uso del adyuvante para preparar composiciones agroquimica
CL2011000285A1 (es) Compuestos derivados de 1-(het)aril-4-fenil-pirazoles; uso de dichos compuestos para combatir plagas de animales; procedimiento para combatir plagas de animales; procedimiento para la preparación de composiciones agroquímicas, y compuestos intermediarios.
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
BRPI0807789A2 (pt) Composição de ração para animal de estimação, ração para animal de estimação, e, uso de uma composição
CL2007003212A1 (es) Compuestos derivados de imidazopirazinas, inhibidores de proteina quinasa; composicion farmaceutica que los comprende; y su uso para tratar cancer.
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
CL2007003735A1 (es) Compuestos derivados de pirimidinilpirazoles; procedimiento para la sintesis de dichos compuestos; uso de dichos compuestos; procedimiento para combatir plagas animales; y procedimiento para la preparacion de composiciones agroquimicas.
BRPI0815821A2 (pt) Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.
CL2007002970A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.